Government price listing
A cash-price example, with its limits
The government’s September 26, 2026 cash-price listing showed a starting price of $149 per month for semaglutide (Wegovy) tablets.
That starting price was for the lowest strength, not every strength or every prescription.
That figure is for the medicine. Ask for a separate total for your visits, tests and other care.
Read the government listing and offer termsWhy another headline can look different
Prices checked September 26, 2026 vary with how you pay: directly, through insurance or through a special programme.
A maker’s published price is called the list price. It is not a personal bill.
- Which kind of price is this?
- What product, form and supply does it cover?
- Does it assume insurance, a first offer or a long commitment?
- What will the next refill cost?
The service fee may be separate
A September 26, 2026 check of six national online care websites found that most charged a monthly membership.
All the services with a membership treated medicine as a separate cost.
A Washington service may charge you different fees from those adverts. Ask for your own written total.
- Are visits included in the membership?
- Are tests, delivery or follow-up charged separately?
- Will a charge repeat automatically?
- How can I stop the charges, and what happens to the bill if no medicine is prescribed?
Put an end date beside the offer
As checked September 26, 2026, several drug-maker offers and savings cards carried terms ending December 31, 2026.
That end date calls for a price recheck; it does not tell us what the next offer will be.
- Save the terms you were given and ask for the ongoing total.